Similar Stories to Nih Authorizes First Human Trial Of Crispr Gene-editing Technique on Bing News

Forget GMO. Get ready for GMH. CRISPR, the genome-editing technology that has taken biomedical science by storm, is finally nearing human trials. On 21 June, an advisory committee at the US National Institutes of Health (NIH) approved a proposal to use CRISPR–Cas9 to help augment cancer therapies that rely on enlisting a patient’s T cells, a type of immune cell. Where some gene modification techniques have involved the brute-force insertion of genetic material (including shooting at cells with an air pistol), CRISPR is a much more exacting technique that offers multiple approaches to carefully editing genes, including human genes. What CRISPR offers, and biologists desire, is specificity: the ability to target and study particular DNA sequences in the vast expanse of a genome.

BING NEWS:
  • Gene editing in agriculture: BTI scientist advocates for CRISPR innovations to senate committee
    Georg Jander, a professor from the Boyce Thompson Institute, addressed an audience in the offices of the U.S. Senate Committee on Agriculture, Nutrition, and Forestry. In a compelling presentation ...
    04/30/2024 - 1:00 pm | View Link
  • Prime Medicine Gets FDA Okay for First Trial of Gene Editing Technique
    The FDA has cleared a clinical trial of an ex vivo prime editing candidate in patients with a rare disease, Prime Medicine announced Monday. The technique taps CRISPR technology to rewrite defective ...
    04/30/2024 - 4:27 am | View Link
  • ‘ChatGPT for CRISPR’ creates new gene-editing tools
    This week, researchers published details of how they used a generative AI tool called a protein language model — a neural network trained on millions of protein sequences — to design CRISPR ...
    04/28/2024 - 1:00 pm | View Link
  • This AI Just Designed a More Precise CRISPR Gene Editor for Human Cells From Scratch
    Based on large language models—the tech behind the popular ChatGPT—Profluent's AI designed a new gene editor and put it to work in human cells.
    04/25/2024 - 9:25 am | View Link
  • Regeneron, Mammoth Launch In Vivo CRISPR Gene Editing Collaboration
    Regeneron Pharmaceuticals will use Mammoth Biosciences’ CRISPR-based ultracompact gene editing platform to develop in vivo therapies for tissues and cell types beyond the liver.
    04/25/2024 - 4:00 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Politics News